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Lower extremity angioplasty: Impact of
practitioner specialty and volume on practice
patterns and healthcare resource utilization
Todd R. Vogel, MD, MPH,a Viktor Y. Dombrovskiy, MD, PhD, MPH,a Jeffrey L. Carson, MD,b
Paul B. Haser, MD,a and Alan M. Graham, MD,a New Brunswick, NJ
Objectives: Lower extremity percutaneous transluminal angioplasty (LE PTA) is currently performed by a variety of
endovascular specialists. We hypothesized that cardiologists (CRD) and vascular surgeons (VAS) may have different
practice patterns, indications for intervention, and hospital resource utilization.
Methods: Using the State Inpatient Databases for New Jersey (2003-2007), patients with elective admission undergoing
PTA procedures with indications of claudication, rest pain, and gangrene/ulceration were examined. Physician specialty
was determined based on all procedures performed. We contrasted by specialty, the indication for LE PTA for the
procedure, volume, and hospital resource utilization.
Results:Of the 1887 cases of LE PTA, VAS performed 866 (45.9%) and CRD1021 (54.1%) procedures. Themean patient
age was 68.0 years (CRD) vs 70.7 years (VAS), P .0163. Indications for intervention were compared for CRD vs VAS:
claudication 80.7% vs 60.7%, (P< .002); rest pain 6.2% vs 16.0%, (P< .002); gangrene/ulceration 13.1% vs 23.3%, (P<
.002). Stents (64.8% of cases) were utilized similarly among physicians (P  .18), and mean hospital length of stay were
similar (2.38 days vs 2.41 days, P  .85). Hospital charges by indication varied between CRD vs VAS (all procedures:
$49,748 vs $42,158 [P< .0001]). Revenue center charges were different between CRD vs VAS: medical surgical supply
$19,128 vs $12,737, (P < .0001); pharmacy $1,959 vs $1,115, (P < .0001). Only 10.7% of CRD were high volume
practitioners, compared with 36.8% among VAS (P < .05). High volume practitioners had significantly lower hospital
charges ($41,730 vs $51,014, P < .001).
Conclusions: Cardiologists performing lower extremity angioplasty were more likely to treat patients with claudication
than those with rest pain or gangrene/ulceration. Despite treating younger patients with less severe peripheral vascular
disease, cardiologists used significantly greater hospital resources. High practitioner volume, regardless of specialty, was
associated with lower hospital resource utilization. Reducing variations in indication and practitioner volume may offer
substantial cost savings for lower extremity endovascular interventions. ( J Vasc Surg 2009;50:1320-5.)The implementation of endovascular technology has
increased substantially, particularly for the management of
lower extremity peripheral arterial disease (PAD). This
rapid evolution has been driven by improved technology,
an increase of the number of practitioners performing lower
extremity percutaneous transluminal angioplasty (LE PTA),
and an aging population. While nationwide rates of lower
extremity surgical revascularization have remained stable or
declined, non-surgical endovascular interventions for PAD
have increased significantly over time.1-3 As well, the num-
ber of LE endovascular procedures performed with the
indication being claudication has dramatically increased
over time.3
From the Division of Vascular Surgery, The Surgical Outcomes Research
Group,a and the Department of Medicine,b Robert Wood Johnson Med-
ical School, The University of Medicine and Dentistry, New Jersey.
Competition of interest: none.
Reprint requests: Todd R. Vogel, MD, MPH, University of Medicine and
Dentistry of New Jersey, Robert Wood JohnsonMedical School, Division
of Vascular Surgery, One Robert Wood Johnson Place - MEB-541, New
Brunswick, New Jersey 08903-0019 (e-mail: vogelto@umdnj.edu).
The editors and reviewers of this article have no relevant financial relation-
ships to disclose per the JVS policy that requires reviewers to decline
review of any manuscript for which they may have a competition of
interest.
0741-5214/$36.00
Copyright © 2009 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.07.112
1320Concurrently, the cost of healthcare continues to rise
and the proportion of the aged in the population will
continue to increase.4 As has been shown previously, hos-
pital resource utilization varies by practitioners performing
endovascular procedures.5 Variation in practice by different
disciplines may significantly increase the costs of health care
while not necessarily improving outcomes. We evaluated
the impact of practitioner specialty and volume with regard
to procedural indications, hospital utilization, and out-
comes associated with LE PTA.
METHODS
Study design. We performed a secondary data analysis
using a statewide hospital administrative discharge data-
base. We evaluated records of inpatient hospitalizations
between 2003 and 2007 to assess the utilization of PTA
and outcomes among patients with PAD.
Data source. We used the publicly available New Jer-
sey State Inpatient Database (SID) for the years of 2003 to
2007, which was developed as part of the Healthcare Cost
and Utilization Project (HCUP) sponsored by the Agency
for Health Care Research and Quality (AHRQ).6 The NJ
SID includes inpatient discharge abstracts from all acute
care (academic and community) hospitals in the state and
contains more than 200 data elements. We utilized demo-
graphic characteristics (age, gender, and race), admission
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ondary procedures, discharge status, physician (surgeon)
identifier, number of days from admission to procedure,
hospital length of stay (LOS), and hospital charges. Using
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) diagnosis codes, we
identified the following postoperative complications: car-
diac complications including myocardial infarction (997.1,
410.x), pulmonary (997.3, 518.4, and 518.5), and renal
(997.5) complications.
Study population. We analyzed patients aged 18
years and older who underwent LE PTA after elective
admission to the hospital. We used the ICD-9-CM proce-
dure code 39.50 (percutaneous transluminal angioplasty
[PTA] of non-coronary vessels) in the principal procedure
position in the data in association with the ICD-9-CM
diagnosis codes 440.2x (atherosclerosis of native arteries of
the extremities) in any diagnosis position. Cases with stent
were selected with the ICD-9-CM procedure code 39.90
(insertion of non-drug-eluting peripheral vessel stent) in
any procedure position in association with the abovemen-
tioned ICD-9-CM diagnosis codes 440.2x. Patients were
categorized into three groups according to the ICD-9
diagnosis codes for atherosclerosis of the extremities with
claudication (440.21), rest pain (440.22), and ulceration
or gangrene (440.23, 440.24). Cases with associated renal,
mesenteric, and cerebral disease diagnoses as well as cases
with missing physician identification number were ex-
cluded.
Practitioner specialty. To identify practitioner spe-
cialty, we used the variable in the NJ SID that identifies the
physician performing the principal procedure. Subsequently,
we divided practitioners into two groups of physicians: car-
diologists (CRD) and vascular surgeons (VAS). The first
step established procedures relevant to each of these spe-
cialties, and the ICD-9-CM codes for these procedures
were as follows: 37.21, 37.22, and 37.23 for interventional
cardiologists; and 38.12, 38.42, 38.44, 38.48, and 39.25
for vascular surgeons (Table I). We then analyzed the
frequency and distribution of these procedures in all obser-
vations in the data set linked to practitioners and then
identified practitioner specialty by procedure types per-
formed.We required that physicians have at least 80% of the
Table I. ICD-9 codes utilized to determine specialist
Interventional cardiologist
37.21 Right heart cardiac catheterization
37.22 Left heart cardiac catheterization
37.23 Combined right and left heart cardiac catheterization
Vascular surgeon
38.12 Carotid endarterectomy
38.42 Resection of vessel with replacement, carotid artery
38.44 Resection of vessel with replacement, abdominal aorta
38.48 Resection of vessel with replacement, lower limb
arteries
39.25 Aorto-iliac-femoral bypass
ICD-9, International Classification of Diseases, Ninth Revision.predetermined codes in a specialty to be classified. Wedefined high-volume practitioners in the upper quartile of
procedures performed.
Statistical analysis. SAS 9.1 software (SAS Institute,
Cary, NC) was utilized for the analysis of the database and
all statistics. To test the difference between groups, we used
X2 analysis with calculating odds ratio (OR) and 95%
confidence interval (95% CI) for categorical variables, Stu-
dent’s t test and SAS PROC GLM (general linear model)
procedure (for two-way unbalanced design) for continuous
variables. A value of P 0.05 was considered significant for
all analyses.
RESULTS
We identified 383 practitioners who performed 2837
LE PTA during the study period. We only included practi-
tioners who performed at least 10 procedures over the
five-year study period. These 70 (18.3%) practitioners
treated 68.3% of all LE PTE cases (1938).We identified the
specialty for 66 providers: 28 cardiologists and 38 vascular
surgeons and only these physicians and their patients (1887
cases) were included in the final analysis. Three cardiolo-
gists and 14 vascular surgeons were identified as high-
volume providers. They accounted for 25.8% of physicians
in the study and they performed 57.9% (1093) of all
procedures.
Sociodemographic characteristics of patients and their
distribution between providers are displayed in Table II.
The majority of study patients were treated by vascular
surgeons (54.1%); 45.9% were treated by cardiologists (P
.0002). Patients in VAS group were older than in CRD
group (70.7 11.0 years vs 68.0 10.7, respectively; P
.0163). In both groups, men predominated over women
but among cardiologists’ patients, this disproportion was
greater (P  .01). Racial demographics for both cohorts
were similar.
We found significant differences in the frequency distri-
bution of various indications for intervention among cardiol-
Table II. Sociodemographic characteristics of patients
Patient characteristic
Physician specialty
Cardiologist Vascular surgeon
Total 866 1021
Age, years:
18-49 43 (5.0%) 42 (4.1%)
50-64 285 (32.9%) 239 (23.4%)
65-79 414 (47.8%) 510 (50.0%)
80 and above 124 (14.3%) 230 (22.5%)
Gender:
Male 529 (61.1%) 564 (55.2%)
Female 337 (38.9%) 457 (44.8%)
Race:
White, non-Hispanic 680 (84.0%) 824 (82.7%)
Black, non-Hispanic 59 (7.3%) 51 (5.1%)
Hispanic 58 (7.2%) 63 (6.3%)
Other 12 (1.5%) 59 (5.9%)
Missed 57 24ogists and vascular surgeons (Table III). Patients treated by
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than CRD patients. VAS patients had a greater proportion
of gangrene/ulceration (23.3% vs 13.1%; P  .0002) and
rest pain (16.0% vs 6.2%; P  .0002) but a significantly
smaller proportion of claudication (60.7% vs 80.7%; P 
.0002).
Table III demonstrates how cardiologists and vascular
surgeons utilized stent for LE PTE. Overall, there was not
a significant difference in the use of stent between cardiol-
ogists (66.4% of all cases) and vascular surgeons (63.5%;
P .18). However, we found a tendency for greater use of
stent for treatment of gangrene or ulceration by vascular
surgeons (52.1%) compared with cardiologists (43.4%; P
.06). For the indication of rest pain, cardiologists tended to
use stents (63.0%) more often then vascular surgeons
(51.5%; P  .07). For the treatment of claudication, VAS
and CRD used stents with the same frequency (71.0% and
Table III. Indications, outcomes and hospital resource
utilization for lower extremity percutaneous transluminal
angioplasty performed by cardiologists and vascular
surgeons
Physician specialty
PCardiologist
Vascular
surgeon
Indications for procedure, %
Claudication 80.7 60.7 .0002
Rest pain 6.2 16.0 .0002
Gangrene/ulceration 13.1 23.3 .0002
Stent utilization, %
Overall 66.4 63.5 .18
Claudication 70.4 71.0 .41
Rest pain 63.0 51.5 .07
Gangrene/ulceration 43.4 52.1 .06
Postoperative complications, %
Pulmonary 0.35 0.20 .52
Cardiac 0.69 0.78 .82
Renal 0.58 0.59 .98
Postoperative mortality, % 0.46 0.10 .18
Hospital length of stay, days
Overall 2.38 2.41 .85
Claudication 1.42 1.45 .80
Rest pain 2.33 1.99 .46
Gangrene/ulceration 3.39 3.81 .21
Total hospital charges, $
Overall 49,748 42,158 .0001
Claudication 46,669 38,100 .0001
Rest pain 59,034 39,755 .0009
Gangrene/ulceration 64,357 54,375 .018
Drug or pharmacy charges, $
Overall 1,959 1,115 .0001
Claudication 1,553 771 .0002
Rest pain 5,040 947 .0001
Gangrene/ulceration 2,998 2,126 .048
Medical surgical supply
charges, $
Overall 19,128 12,737 .0001
Claudication 19,050 12,448 .0001
Rest pain 17,081 13,010 .148
Gangrene/ulceration 20,587 13,302 .000470.4%, respectively; P  .41).The rates of postoperative complications in our study
were low: 0.26% for pulmonary, 0.58% for renal, and 0.74%
for cardiac complications. We did not find differences in the
rates of any of these complications whether these interven-
tions were performed by cardiologists or vascular surgeons.
Hospital mortality was also low and was similar between
groups (VAS: 0.10%; CRD: 0.46%; P  .18 utilizing Fish-
er’s exact test).
The main differences between cardiologists and vascu-
lar surgeons were found in the analysis of hospital resource
utilization. We did not find differences in hospital LOS
between cardiologists and vascular surgeons in the entire
cohort (2.38 days vs 2.41 days; P  .85) or by indications:
gangrene/ulceration (3.39 vs 3.81; P  .21), rest pain
(2.33 vs 1.99; P .46) and claudication (1.42 vs 1.45; P
.8). However, significant differences in hospital charges
were found between providers. Total hospital charges for
cardiologists were greater than for vascular surgeons:
$49,748 vs $42,158 (P  .0001) in the entire cohort;
$46,669 vs $38,100 (P  .0001) for patients with claudi-
cation; $59,034 vs $39,755 (P  .0009) for patients with
rest pain; and $64,357 vs $54,375 (P  .018) for patients
with gangrene or ulceration.
We found significant differences in drug and pharmacy
charges between cardiologists and vascular surgeons: $1,959
vs $1,115 (P  .0001) in the entire cohort; $2,998 vs
$2,126 (P  .048) for patients with gangrene/ulceration;
$5,040 vs $947 (P .0001) for patients with rest pain and
$1,553 vs $771 (P  .0002) in those patients with claudi-
cation. Medical surgical supply charges among cardiologist
were also greater than for vascular surgeons: $19,128 vs
$12,737 (P  .0001) in the entire cohort; $20,587 vs
$13,302 (P  .0004) among patients with gangrene/
ulceration and $19,050 vs $12,448 (P  .0001) among
patients with claudication; this was not seen with rest pain
($17,081 vs $13.010; P  .148). The potential savings in
total hospital charges if cardiologists had practice patterns
similar to vascular surgeons was calculated to be approxi-
mately $8.16 million for total hospital charges, including
$5.99 million for the treatment of claudication, $1.04
million for the treatment of rest pain, and $1.13 million for
the treatment of ulceration or gangrene.
We also analyzed total hospital charges by practitioner
volume. High-volume practitioners were defined as having
procedural volume in the upper quartile. High volume prac-
titioners were 25.8% of the entire group of physicians and
accounted for 57.9% of all LE PTA procedures. Low volume
physicians were found to have significantly greater
charges than their high volume colleagues ($51,014 vs
$41,730; P .0001). This was present for both cardiologists
($55,131 vs $45,085; P  .0001) and vascular surgeons
($46,803 vs $39,252; P .002).
DISCUSSION
Many authors have described that the utilization of
lower extremity angioplasty has greatly increased over the
past several years,2,3,7 yet few data exist evaluating the
association between practitioner type, the indications for
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utilization. Some suggested reasons for the increased utili-
zation of lower extremity angioplastymay be the availability
of new technology, a change in threshold for intervention,
or the practitioners performing these interventions. For
these reasons, we evaluated the indications for procedure
and subsequent healthcare resource utilization based on
practitioner specialty to identify variability for intervention.
We have demonstrated significant variation among practi-
tioners with regard to LE intervention and resource utili-
zation. Patients treated by vascular surgeons had more
severe indications with greater proportions of patients hav-
ing indications of rest pain, ulceration, and gangrene com-
pared with cardiologists. Epidemiological studies have
demonstrated that up to 5% of men and 2.5% of women 60
years of age and older have symptoms of claudication, while
only 20% to 30% of these patients will have progressive
symptoms requiring intervention, and less than 10% ever
require amputation and can be managed with best medical
therapy.8-10 This being stated, a significant disparity in the
treatment of patients with claudication was found by the
practitioners in this study. Cardiologists were significantly
more likely to treat patients with claudication, and in one
year of the study 90% of the patients treated by cardiologists
were claudicants.
Variation among practice patterns and specialists has
been evaluated in many areas of medicine. Evaluation of
resource utilization for medical specialties for the manage-
ment of general medical patients has demonstrated that
increased utilization was independently related to specia-
lty.11 As well, others have evaluated variation in the out-
comes of surgical procedures evaluating training and vol-
ume. Although research has suggested the importance of
specialty training, the reasons underlying variation in sur-
gical mortality remain largely unknown.12
Furthermore, the impact of increased lower extremity
interventions with endovascular therapy is yet to be deter-
mined. Rowe et al analyzed population-based rates of ma-
jor amputations for PAD during a time period in which the
use of endovascular surgical procedures increased and con-
cluded that the last decade has seen a significant increase in
the use of endovascular procedures and a decrease in rates
of major amputation. They suggested an association be-
tween increased application of endovascular technology
and reduced rates of amputation in patients with PAD.1
Differing results utilizing other national data have been
reported by Feinglass et al. They concluded that major
amputation rates fell in the years following the diffusion of
distal bypass surgery but before the widespread use of
peripheral angioplasty. This study suggested that the con-
tribution of recent changes in vascular surgery is difficult to
demonstrate with respect to limb preservation.13
Beyond the variations for indications demonstrated
from this data, we have shown that hospital resource utili-
zation was significantly disparate based on the practitioner
for LE PTA. Total hospital charges for cardiologists were
greater than for vascular surgeons for all indications exam-
ined. These data demonstrate that cardiologists were morelikely to treat patients with less severe PAD and utilize
greater hospital resources to perform this task. Cardiologists
had increased total hospital charges, pharmacy charges, and
medical surgical supply charges. Reasons for these significant
variations in cost may include the number of catheters
utilized for each procedure, the types of equipment uti-
lized, and intra-hospital consults and practice patterns.
Previous data have demonstrated significant hospital re-
source utilization disparities among endovascular practitio-
ners with regard to carotid interventions.5
These data are particularly important as there is an
intensified interest in decreasing the cost of health care.
Davis reported on the overuse, inappropriate, or ineffective
use of care with the introduction of new technologies
without comparative information on clinical outcomes or
cost-effectiveness as reasons for increased health care ex-
penditures.14 If the disparities between practitioners from
these data are placed into an economic framework, there
would be a significant cost saving by utilizing the practice
patterns of vascular surgeons. In the state, it was estimated
that an approximate overall savings of 8.16 million dollars
in hospital charges for the treatment of PAD could have
been saved utilizing the practice patterns of vascular sur-
geons. The impact of these savings from one state when
extrapolated to the nation could offer significant future cost
saving strategies.
To further evaluate variation by practitioner, volume
characteristics were analyzed. Low volume physicians, re-
gardless of specialty, had greater charges than their high
volume counterparts. These data suggest that disparities
noted for LE PTA are influenced by practitioner volume.
Volume has been a well described predictor of outcomes in
many areas of surgery and vascular surgery.5,7,12,15-17 As
well, the use of volume as a marker of quality and a
surrogate for outcomes has been evaluated for multiple
surgical procedures. Birkmeyer et al have evaluated this
phenomenon for a variety of surgical procedures and con-
cluded that for many procedures, the observed associations
between hospital volume and operativemortality are largely
mediated by surgeon volume.12,16,17 Patients can often
improve their chances of survival substantially, even at
high-volume hospitals, by selecting surgeons who perform
the operations frequently.17
Limitations for this study include that the SID database
does not contain patients from military hospitals or Veter-
ans Administration medical centers. The potential for in-
clusion bias based on limited coding schemes cannot be
entirely excluded, as well as confounding by indication for
the procedures performed. The SID is an administrative
discharge data set based on billing and the data are limited
by the coding schemes created by AHRQ and ICD-9
codes. It is possible that the definition of indications and
coding may vary within the data set and may vary between
institutions and hospital coders. As well, ICD-9 procedure
codes do not specify the anatomic level of intervention. If
general surgeons or cardiothoracic surgeons were perform-
ing a compliment of angioplasty and open vascular surgery,
they have been placed in the vascular surgeon group. As
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using this methodology and were excluded from the anal-
ysis. Finally, there is a bias in this study as all the procedures
were performed in hospitals and no outpatient facilities are
contained within the data set.
In conclusion, physician specialty was not found to
significantly influence patient outcomes or complications
for LE PTA. We have demonstrated that hospital resource
utilization varied significantly by specialty with vascular
surgeons demonstrating the lowest utilization of hospital
resources for LE PTA compared to cardiologists. We found
that high volume practitioners also used significantly fewer
medical supplies and had lower hospital resource utilization
for performing LE PTA. Furthermore, cardiologists were
more likely treat claudicants with greater use of hospital
resources. Explanations for these variations remains un-
clear, but further analysis to explain these disparities may
offer substantial cost savings for lower extremity angio-
plasty in the future.
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Dr G. Patrick Clagett (Dallas, Tex). Where do the interven-
tional radiologists stand?
Dr Vogel.We analyzed the volume of interventional radiolo-
gists utilizing the same methodology in this presentation and a
previously published study. In the state of New Jersey, the inter-
ventional radiologists have had a significant reduction in case
volume in the years analyzed. The volume was insufficient to
perform a comparative analysis.
DrMaciej Dryjski (Buffalo, NY). I have one question. Could
you tell us a little bit more about this database? Was it only
hospitalized patients or also outpatients? If in fact only inpatients
were included, you missed a great number of endovascular cases.
Dr Vogel.We utilized the publicly available New Jersey State
Inpatient Database (SID), which was developed as part of the
Healthcare Cost and Utilization Project (HCUP) sponsored by
the Agency for Health Care Research and Quality (AHRQ). The
NJ SID includes inpatient discharge abstracts from all acute care
hospitals in the state and contains more than 200 data elements.
The data are based on ICD-9 codes, which are primarily billingIndications for the procedure of angioplasty included claudication,
rest pain, and gangrene.
The data set contains only inpatient admissions and does not
include surgicenters. Therefore, this study may be biased for a
sicker cohort, as they were all performed in the hospital setting.
DrDryjski.Themajority of angioplasties are performed on an
outpatient basis, particularly by cardiologists.
Dr Vogel. If procedures are performed in a hospital setting,
they are likely contained within the data set, although this data set
does not contain outpatient surgicenters.
Dr Gary Giangola (Staten Island, NY). I’m not here to
defend the cardiologists, but if one were to do a prospective study,
one would find that vascular surgeons probably are doing interven-
tion on a higher percentage of claudicants than you obtained in this
retrospective New Jersey state database. Cardiologists are more
inclined to list the indication as claudication. Vascular surgeons
should know better than to treat claudication and aremore likely to
exaggerate and list the indication as rest pain or ischemic ulcer for
minimal skin problems in the foot. I would predict that in a
prospective study, one would find that vascular surgeons are treat-
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study indicates, a practice that we need to question.
Dr Vogel. I agree. Neither specialty can be defined as “saints.”
The reality is that we can debate whether or not claudication should
even be treated with an intervention. Both specialties will need to
address the issue of interventions on claudicants in the future and, in
my opinion, create defined guidelines for intervention.
Dr Giangola. You re-emphasize a good point. The issue is:
How should we treat claudication?
Dr Vogel. An excellent example is carotid stenting. Carotid
stenting has been tempered by strict criteria linked to reimburse-
ment. Perhaps guidelines linked to reimbursement are required for
lower extremity angioplasty in the management of claudicants.
Dr Ralph Pfeiffer (Mobile, Ala). I appreciate your data. Your
data reflect our own experience in Mobile.
Dr Peter Paik (Irvine, Calif). My question is, when these
cardiologists were doing these procedures, were they doing them
as an additional procedure? Were they doing angiograms for
cardiology purposes?
Dr Vogel. This information cannot be discerned from the
data. However, I can tell you that angioplasty that was non-Dr Paik. From my local experience, a lot of cardiologists are
actually performing these procedures, since they’re doing angio-
gram and they know the patient has claudication, they usually go
down and intervene in those, so that may be a factor.
Dr Vogel. Perhaps.
Dr Hasan Dosluoglu (Buffalo, NY). I’d like to make a
comment about your comment that we’re not saints. In the VA
population, it’s about 65% to 70% critical limb ischemia, and 30%
claudicants. So it is unfortunate that the VA with its different
reimbursement system is not included in this analysis. I’d like to
hear your comment on that.
And second, what constituted the difference in cost between
the cardiologists and the vascular surgeons? Were the cardiologists
using more stents or other toys for re-entry, or laser?
Dr Vogel. Unfortunately I cannot comment on the VA
system as it is not contained within the state data set sponsored by
AHRQ. Regarding cost based on specialist, one would need to
perform a root cause hospital-based analysis. My hypothesis is that
different specialties utilize more catheters, wires, reentry devices,
and ultrasound. All of these entities add to the total procedural costcoronary was the principal procedure for the cohort we evaluated. captured in the data I have presented.
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